| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790086 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
Our results indicated that patients with UCC carrying rs2977530 genetic variants (AG + GG) have a higher risk of developing a more invasive tumor stage and a large tumor. WISP1 polymorphisms may serve as a marker or a therapeutic target in UCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hsiang-Lin M.D., Hui-Ling Ph.D., Shian-Shiang M.D., Ph.D., Sheng-Chun M.D., Ming-Chih M.D., Ph.D., Shun-Fa Ph.D., Ming-Ju Ph.D., Ying-Erh Ph.D.,